Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005223101 | SCV005865253 | pathogenic | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-12-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu2130*) in the FBN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of FBN1-related conditions (PMID: 29848614, 34916231). ClinVar contains an entry for this variant (Variation ID: 549342). For these reasons, this variant has been classified as Pathogenic. |
Center for Medical Genetics Ghent, |
RCV000663866 | SCV000787226 | pathogenic | Marfan syndrome | 2017-11-07 | no assertion criteria provided | clinical testing |